Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
$656K Hold
3,167
0.33% 64
2018
Q2
$585K Hold
3,167
0.31% 71
2018
Q1
$540K Hold
3,167
0.29% 72
2017
Q4
$551K Sell
3,167
-300
-9% -$53.1K 0.29% 76
2017
Q3
$646K Hold
3,467
0.34% 79
2017
Q2
$597K Buy
3,467
+1,450
+72% +$236K 0.32% 75
2017
Q1
$331K Sell
2,017
-233
-10% -$38.7K 0.17% 87
2016
Q4
$329K Buy
2,250
+850
+61% +$128K 0.18% 91
2016
Q3
$234K Buy
+1,400
New +$237K 0.13% 94

Other funds holding AMGN

Laurel Grove Capital's AMGN Position: Q3 2018 in Review

Laurel Grove Capital held its Amgen (AMGN) position steady in Q3 2018 at 3,167 shares worth $656K. The position accounts for 0.33% of the portfolio, ranked #64.

Laurel Grove Capital first reported a position in AMGN in Q3 2016 and has held it in 9 quarters since. 1,797 funds tracked by Wall St. Rank hold AMGN as of Q3 2018.

  • Laurel Grove Capital held 3,167 shares of Amgen worth $656K as of Q3 2018.
  • Laurel Grove Capital left its Amgen share count unchanged in Q3 2018.
  • Amgen made up 0.33% of Laurel Grove Capital's portfolio in Q3 2018, its #64 holding.
  • Laurel Grove Capital first reported a position in Amgen in Q3 2016 and has held it in 9 quarters since.
  • 1,797 funds tracked by Wall St. Rank held Amgen as of Q3 2018.

Based on Laurel Grove Capital's 13F filing for Q3 2018, filed 12 Oct 2018.